Effect of androgen ablation on prostatic cell differentiation in dogs

Endocrine Research

Volumn 30, Issue 3, 2004, Pages 327-334

  Shidaifat, Falah ^a   Daradka, M ^a   Al Omari, R ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Actin; Castration; Cytokeratin; Differentiation; Dog; Vimentin

Indexed keywords

ALPHA ACTIN; ANDROGEN; CYTOKERATIN; VIMENTIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASAL CELL; CASTRATION; CELL DEATH; CELL DIFFERENTIATION; CELL SECRETION; CONTROLLED STUDY; DOG; HORMONE ACTION; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYME CELL; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; SMOOTH MUSCLE; STEM CELL;

ACTINS; ANDROGENS; ANIMALS; CASTRATION; CELL DIFFERENTIATION; DOGS; EPITHELIAL CELLS; KERATINS; MALE; MUSCLE CELLS; PROSTATE; RANDOM ALLOCATION; STEM CELLS; TESTIS; VIMENTIN;

EID: 7544220620     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1081/ERC-200033196     Document Type: Article

References (24)

1. Liu AY, True LD, LaTray L, Nelson PS, Ellis WJ, Vessella RL, Lange PH, Hood L, Engh GV. Cell-cell interaction in prostate gene regulation and cytodifferentiation. Proc Natl Acad Sci 1997; 94:10705-10710.
2. Furuya Y, Lin XS, Walsh JC, Nelson WG, Isaacs JT. Androgen ablation - induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction. Endocrinology 1995; 136:1898-1906.
3. Kyprianou N, Isaacs JT. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 1988; 122:552-562.
4. Martikainen P, Isaacs JT. An organ culture system for the study of programmed cell death in the rat ventral prostate. Endocrinology 1990; 127:1268-1277.
5. Mirosecvich J, Bentel JM, Zeps N, Redmond SL, Dantuono MF, Dawkins HJS. Androgen receptor expression of proliferating basal and luminal cells in adult murine ventral prostate. J Endocrinol 1999; 162:341-350.
6. Waltregny D, Leav I, Signoretti S, Soung P, Lin D, Merk F, Adams JY, Bhattacharya N, Cirenei N, Loda M. Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27. Mol Endocrinol 2001; 15:765-782.
7. Kyprianou N, English HF, Isaacs JT. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 1990; 50:3748-3753.
8. kip1 in androgen-induced cell cycle arrest. Mol Endocrinol 1988; 12:941-953.
9. Shen R, Sumitomo M, Dai J, Harris A, Kaminetzky D, Gao M, Burnstein KL, Nanus DM. Androgen-induced growth inhibition of androgen receptor expressing androgen-independent prostate cancer cells is mediated by increased levels of neutral endopeptidase. Endocrinology 2000; 141:1699-1704.
10. Prehn RT. On the prevention and therapy of prostate cancer by androgen administration. Cancer Res 1999; 59:4161-4164.
11. Umekita Y, Hiipakka RA, Kokontis JM, Liao S. Human prostate tumor growth in athymic mice: inhibition by androgen and stimulation by finasteride. Proc Natl Acad Sci 1996; 93:11802-11807.
12. Cornell KK, Bostwick DG, Cooley DM, Hall G, Harvey HJ, Hendrick MJ, Pauli BU, Render JA, Stoica G, Sweet DC, Waters DJ. Clinical and pathologic aspects of spontaneous canine prostate carcinoma: a retrospective analysis of 76 cases. Prostate 2000; 45:173-183.
13. Bell FW, Klausner JS, Hayden DW, Feeney DA, Johnston SD. Clinical and pathologic features of prostatic adenocarcinoma in sexually intact and castrated dogs: 31 cases (1970-1987). J Am Vet Med Assoc 1991; 199:1623-1630.
14. Webber MM, Trakul N, Thraves PS, Bello-DeOcampo D, Chu WW, Storto PD, Huard TK, Rhim JS, Williams DE. A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interaction in prostatic neoplasia. Carcinogenesis 1999; 20:1185-1192.
15. Crane WS. Orchiectomy of descendent and retained testes in the dogs and cats. In: Bojrab M, ed. Current Techniques in Small Animal Surgery. Philadelphia: Lea & Febiger, 1990:416-422.
16. Arnold JT, Isaacs JT. Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault. Endocr-Relat Cancer 2002; 9:61-73.
17. Prins GS, Birch L, Greene GL. Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 1991; 129:3187-3199.
18. Whitacre DC, Chauhan S, Davis T, Gordon D, Crees AE, Miesfeld RL. Androgen induction of in vitro prostate cell differentiation. Cell Growth Differ 2002; 13:1-11.
19. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 2002; 8:2912-2923.
20. Hayward SW, Baskin LS, Haughney PC, Foster BA, Cunha AR, Dahiya R, Prins GS, Cunha GR. Stromal development in the ventral prostate, anterior prostate and seminal vesicle of the rat. Acta Anat 1996; 155:94-103.
21. Grossfeld GD, Hayward SW, Tlsty TD, Cunha GR. The role of stroma in prostatic carcinogenesis. Endocr-Relat Cancer 1998; 5:253-270.
22. Cunha GR. Role of mesenchymal-epithelial interaction in normal and abnormal development of the mammary gland and prostate. Cancer 1994; 74:1030-1044.
23. Thomson AA. Role of androgens and fibroblast growth factors in prostatic development. Reproduction 2001; 121:187-195.
24. Lang SH, Hyde C, Reid IN, Hitchcock IS, Hart CA, Bryden AA, Villette JM, Stower MJ, Maitland NJ. Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma. Prostate 2002; 52:253-263.